Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study details. This indicates that access to the content is currently blocked.SummaryDifference18%

- Check34 days agoChange DetectedA funding entry for 2016 ( U.S. NIH Grant/Contract ) was added to the study page. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new site revision was deployed.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a small platform update to the ClinicalTrials.gov study page rather than a change to the study details themselves.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2. This indicates a minor platform update and does not modify the study data or displayed information.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded key study documents (Study Protocol and Statistical Analysis Plans) and IPD data-sharing information. Updated record history metadata reflects recent postings and verification dates, improving transparency of the trial documentation.SummaryDifference65%

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.